NASDAQ:GERN
Geron Corporation Stock News
$3.81
-0.0900 (-2.31%)
At Close: May 17, 2024
Top Ranked Momentum Stocks to Buy for June 2nd
01:08pm, Tuesday, 02'nd Jun 2020
Top Ranked Momentum Stocks to Buy for June 2nd
Cantor Fitzgerald Maintains Overweight on Geron, Raises Price Target to $4
11:13am, Monday, 01'st Jun 2020Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript
09:00pm, Friday, 29'th May 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Geron Earnings Conference Call. Also joining me today are Aleksandra Rizo, our Chief Medical Officer; and Anil Kapur, our H
Geron shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
12:48pm, Friday, 29'th May 2020B. Riley FBR Maintains Buy on Geron, Raises Price Target to $4
12:13pm, Friday, 29'th May 2020Edited Transcript of GERN earnings conference call or presentation 28-May-20 8:30pm GMT
02:52am, Friday, 29'th May 2020
Q1 2020 Geron Corp Earnings Call
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
10:25pm, Thursday, 28'th May 2020
Geron (GERN) delivered earnings and revenue surprises of 11.11% and -52.73%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Geron Q1 EPS $(0.08) Beats $(0.12) Estimate, Sales $52.00K Beat $50.00K Estimate
08:10pm, Thursday, 28'th May 2020Geron Corporation Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 28'th May 2020
MENLO PARK, Calif., May 28, 2020 -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a.
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:00am, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 27)
ADC Therapeutics SA (NYSE:...
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
08:30pm, Wednesday, 27'th May 2020
Geron Corporation (GERN), a late-stage clinical biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 107,049,375 shares of its common stoc
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
12:00am, Wednesday, 27'th May 2020Alnylam's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:ALNY)
07:44am, Sunday, 24'th May 2020
Alnylam announces positive ONPATTRO trial data. Geron to start phase 3 trial in Myelofibrosis. Atara reports successful early stage data.
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
